Brief: Bergenbio Presents Data On Anti-Axl Antibody Tilvestamab At 32 Ena

Oncoinvent ASA

14/10/2020 06:02

Oct 14 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO PRESENTS DATA ON ANTI-AXL ANTIBODY TILVESTAMAB AT 32 ND  ENA
    * TILVESTAMAB PREVENTS AXL MEDIATED CELL SIGNALING IN CANCER CELL LINES, REDUCES CELL
MIGRATION
AND INVASION
    * TILVESTAMAB SHOWS ANTI-TUMOR EFFICACY IN A PANEL OF MOUSE XENOGRAFT MODELS

Source text for Eikon:  ID:nObiY3zSBa 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))